Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Efreen Horacio Montaño-Figueroa is active.

Publication


Featured researches published by Efreen Horacio Montaño-Figueroa.


Clinical Lymphoma, Myeloma & Leukemia | 2017

Acute Leukemia Characteristics are Different Around the World: the Mexican Perspective

David Gómez-Almaguer; Edson René Marcos-Ramírez; Efreen Horacio Montaño-Figueroa; Guillermo J. Ruiz-Argüelles; Carlos Roberto Best-Aguilera; María del Carmen López-Sánchez; Esperanza Barrera-Chairez; José Luis López-Arrollo; Christian Omar Ramos-Peñafiel; Andrés A León-Peña; Elías Eugenio González-López; Perla Edith Rivas-García; Carlos Alberto Tellez-Hinojosa; Andrés Gómez-De León

Micro‐Abstract In Mexico, there are no large‐scale studies regarding acute leukemia epidemiology. This multicenter, retrospective study evaluated 1018 patients. A similar prevalence for acute lymphoblastic leukemia versus acute myeloid leukemia was found. Less positivity for the Philadelphia chromosome was observed. Acute myeloid leukemia occurred in younger patients, most frequently as an M3 variant. This study is the largest ever performed in Mexico regarding acute leukemia epidemiology. Background: The incidence of acute leukemia (AL) has increased. Its prognosis is variable and depends on several baseline characteristics with a highly heterogeneous presentation. In Mexico, large‐scale descriptive studies have not yet been published; the objective of this study was to analyze the initial basic characteristics of patients diagnosed with AL in our population. Patients and Methods: In this multicenter, retrospective study, 1018 patients ≥ 16 years of age and diagnosed with AL between 2009 and 2014, were included. We described age, gender, complete blood count, and AL subtype according to flow cytometry analysis. Results: Acute lymphoblastic leukemia (ALL) was as common as acute myeloid leukemia (AML) (51% vs. 49%). The median age was 31 years. Only 9.6% of patients with ALL were positive for the Philadelphia chromosome. No gender differences were observed. The median age at presentation of AML was 43 years. Acute promyelocytic leukemia was the most frequent AML subtype (38.3%), with a median age of 37 years. Conclusion: ALL is equally as frequent as AML in patients ≥16 years of age. Philadelphia‐positive prevalence is less frequent than that reported in literature. AML cases occur in a younger age in comparison with other countries. There is a higher rate of acute promyelocytic leukemia among our patients compared with other non‐Latin American populations. This study is the largest ever performed in Mexico regarding descriptive AL data.


Revista médica del Instituto Mexicano del Seguro Social | 2012

Frecuencia de leucemias agudas en un hospital de referencia

Wendy Marlene González-Salas; Irma Olarte-Carrillo; Mario Gutiérrez-Romero; Efreen Horacio Montaño-Figueroa; Carlos Martínez-Murillo; Christian Omar Ramos-Peñafiel


Revista Médica del Hospital General de México | 2015

Megaloblastic anaemia: Folic acid and vitamin B12 metabolism

H.B. Castellanos-Sinco; Christian Omar Ramos-Peñafiel; Adrián Santoyo-Sánchez; J. Collazo-Jaloma; Carlos Martínez-Murillo; Efreen Horacio Montaño-Figueroa; A. Sinco-Ángeles


Revista médica del Instituto Mexicano del Seguro Social | 2012

Acute leukemia frequency observed in a reference hospital

Wendy Marlene González-Salas; Irma Olarte-Carrillo; Mario Gutiérrez-Romero; Efreen Horacio Montaño-Figueroa; Carlos Martínez-Murillo; Christian Omar Ramos-Peñafiel


Revista Médica del Hospital General de México | 2010

Trombofilia primaria en México: experiencia de una institución

Carlos Martínez-Murillo; Angélica Romo-Jiménez; César Zavala-Hernández; Elizabeth Gaminio-Gómez; Efreen Horacio Montaño-Figueroa; Christian Omar Ramos-Peñafiel; J. Collazo-Jaloma


Revista Colombiana de Cancerología | 2016

Factores pronósticos de remisión en pacientes con leucemia linfoblástica aguda posterior a primer recaída

Christian Omar Ramos-Peñafiel; Irma Olarte-Carrillo; Adrián Santoyo-Sánchez; Humberto Castellanos-Sinco; Efreen Horacio Montaño-Figueroa; Guadalupe León-González; Silvia Cabrera-Ozuna; J. Collazo-Jaloma; Adolfo Martínez-Tovar


Archive | 2016

Leucemia aguda mieloide en el viejo. Valoración integral y decisión terapéutica Acute myeloid leukemia in the elderly. Thorough evaluation and thera- peutic decision

Efreen Horacio Montaño-Figueroa; María Guadalupe Honorato-Rosales; Christian Omar Ramos-Peñafiel


Archive | 2016

Trombofilia primaria en México: experiencia de una institución Primary thrombophilia in Mexico; experience of a single institution

Carlos Martínez-Murillo; Angélica Romo-Jiménez; César Zavala-Hernández; Elizabeth Gaminio-Gómez; Efreen Horacio Montaño-Figueroa; Christian Omar Ramos-Peñafiel; Juan Collazo-Jaloma


Archive | 2016

Células progenitoras hematopoyéticas de sangre de cordón umbilical Hematopoyetic stem cells from umbilical cord blood

Efreen Horacio Montaño-Figueroa; Julieta Rojo-Medina


Revista de Hematología | 2011

Eficacia de la quimioterapia intratecal con triple droga en pacientes con leucemia linfoide aguda

Christian Omar Ramos-Peñafiel; Humberto Castellanos-Sinco; Adolfo Martínez-Tovar; Efreen Horacio Montaño-Figueroa; Carlos Martínez-Murillo; Irma Olarte-Carrillo; Juan Collazo-Jaloma; Etta Rozen-Fuller

Collaboration


Dive into the Efreen Horacio Montaño-Figueroa's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

J. Collazo-Jaloma

Hospital General de México

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Juan Collazo-Jaloma

Mexican Social Security Institute

View shared research outputs
Top Co-Authors

Avatar

Adrián Santoyo-Sánchez

National Autonomous University of Mexico

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge